- Home
- MNSB vs PMI Comparison
MNSB vs PMI Comparison
Compare MNSB & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- PMI
- Stock Information
- Founded
- MNSB 2003
- PMI 1981
- Country
- MNSB United States
- PMI United States
- Employees
- MNSB N/A
- PMI N/A
- Industry
- MNSB Major Banks
- PMI
- Sector
- MNSB Finance
- PMI
- Exchange
- MNSB Nasdaq
- PMI Nasdaq
- Market Cap
- MNSB 170.1M
- PMI 202.7M
- IPO Year
- MNSB N/A
- PMI 2025
- Fundamental
- Price
- MNSB $18.58
- PMI $3.30
- Analyst Decision
- MNSB
- PMI
- Analyst Count
- MNSB 0
- PMI 0
- Target Price
- MNSB N/A
- PMI N/A
- AVG Volume (30 Days)
- MNSB 39.1K
- PMI 3.4M
- Earning Date
- MNSB 10-27-2025
- PMI 12-16-2025
- Dividend Yield
- MNSB 2.15%
- PMI N/A
- EPS Growth
- MNSB N/A
- PMI N/A
- EPS
- MNSB N/A
- PMI N/A
- Revenue
- MNSB $69,367,000.00
- PMI $4,461,000.00
- Revenue This Year
- MNSB $23.19
- PMI N/A
- Revenue Next Year
- MNSB $2.92
- PMI N/A
- P/E Ratio
- MNSB N/A
- PMI N/A
- Revenue Growth
- MNSB 9.71
- PMI 1.36
- 52 Week Low
- MNSB $15.00
- PMI $2.60
- 52 Week High
- MNSB $22.98
- PMI $13.68
- Technical
- Relative Strength Index (RSI)
- MNSB 39.26
- PMI N/A
- Support Level
- MNSB $18.30
- PMI N/A
- Resistance Level
- MNSB $18.94
- PMI N/A
- Average True Range (ATR)
- MNSB 0.46
- PMI 0.00
- MACD
- MNSB 0.06
- PMI 0.00
- Stochastic Oscillator
- MNSB 35.29
- PMI 0.00
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.